International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 966-975
Research Article
Comparison of Free Flap versus Pedicled Flap Reconstruction in Oral Cavity Malignancies: A Retrospective–Prospective Cohort Study
 ,
 ,
Received
April 20, 2026
Accepted
May 11, 2026
Published
May 21, 2026
Abstract

Background: Reconstruction following curative resection of oral cavity malignancies is essential for restoring form, function, and quality of life. Although microvascular free flaps are increasingly preferred for complex defects, pedicled flaps remain widely used, particularly in resource-limited settings.

Objective: To compare perioperative outcomes, postoperative complications, functional recovery, quality of life, delay in adjuvant therapy, recurrence, and mortality between free flap and pedicled flap reconstruction in patients with oral cavity malignancy.

Methods: This retrospective–prospective cohort study included 150 patients with histologically confirmed oral cavity malignancy who underwent curative-intent resection followed by immediate flap reconstruction. Patients were categorized into free flap and pedicled flap groups. Demographic, clinicopathological, operative, postoperative, functional, quality-of-life, adjuvant therapy, recurrence, and mortality data were analysed. Intergroup comparisons were performed using appropriate statistical tests, with p <0.05 considered significant.

Results: Free flap reconstruction was associated with better postoperative functional outcomes, including speech, swallowing, mouth opening, and overall quality of life. Pedicled flap reconstruction showed a higher burden of postoperative complications and was more frequently associated with delay in initiation of adjuvant therapy. Recurrence and mortality were influenced by multiple oncological and patient-related factors rather than reconstructive method alone.

Conclusion: Free flap reconstruction provides superior functional rehabilitation and lower postoperative morbidity in suitable patients undergoing oral cavity cancer reconstruction. Pedicled flaps remain valuable alternatives in patients with significant comorbidity, financial constraints, high anaesthetic risk, or limited access to microsurgical facilities. Flap selection should be individualized according to defect characteristics, patient fitness, oncological requirements, and institutional resources.

Keywords
INTRODUCTION

Surgical resection is a key component of the curative treatment of resectable oral cavity malignancies and ablative surgery frequently leads to complex defects that affect speech, swallowing, mastication, oral competence, cosmesis and quality of life, especially in India where tobacco, areca nut use, alcohol consumption and late presentation play significant roles in the incidence and advanced stage presentation of oral cavity cancers. [1,2] Thus, adequate reconstruction is not only necessary for wound closure, but also for functional rehabilitation and timely delivery of adjuvant therapy.

 

Both pedicled regional flaps and microvascular free flaps are widely used for reconstruction of oral cavity defects. However, the pectoralis major myocutaneous flap is technically simple, has a good vascularity, a shorter operating time, and can be used in patients with significant comorbidity or limited access to microsurgical facilities.

 

The free flap versus pedicled flap reconstruction is still clinically relevant particularly in high-volume and resource-limited centres. The functional and quality-of-life results also have been shown to be superior with free flaps, and pedicled flaps remain important in select patients due to their lower cost, less complex surgery, and greater availability. Postoperative complications can also affect oncological outcomes by increasing the length of hospital stay and delaying the start of adjuvant radiotherapy, which is a known predictor of survival in head and neck cancers treated with surgery.

 

There is not much institution-specific evidence from Northeast India to compare these reconstructive approaches in oral cavity malignancy. Hence, the purpose of this study was to compare the perioperative, reconstructive, functional and short-term oncological outcomes of patients with oral cavity malignancies who underwent free flap and pedicled flap reconstruction at Assam Medical College and Hospital, Dibrugarh, Assam.

 

OBJECTIVES

  1. Compare operative time, blood loss, ICU stay, hospital stay, oral intake day, and cost.
  2. Compare flap loss, wound dehiscence, fistula, infection, donor-site morbidity, re-exploration, and overall complications.
  3. Compare speech, swallowing, mouth opening, QoL, adjuvant delay, recurrence, and mortality.

 

METHODS

Study design and setting

This retrospective–prospective cohort study was conducted in the Department of Plastic Surgery, Assam Medical College and Hospital, Dibrugarh. Patients with oral cavity malignancy who underwent curative-intent surgical resection followed by immediate flap reconstruction were included. The study compared outcomes between patients reconstructed with microvascular free flaps and those reconstructed with pedicled flaps.

 

Study population

A total of 150 patients with histologically confirmed oral cavity malignancy were included. Patients were eligible if they underwent primary tumour resection with neck dissection, where indicated, followed by immediate reconstruction using either a free flap or a pedicled flap. Patients with incomplete records, recurrent malignancy at presentation, distant metastasis, palliative surgery, or inadequate follow-up were excluded.

 

Reconstructive procedures

Patients were divided into two groups according to the type of reconstruction performed. The free flap group included patients reconstructed with microvascular free tissue transfer, such as radial forearm free flap, anterolateral thigh flap, or other appropriate free flaps based on defect characteristics. The pedicled flap group included patients reconstructed with regional pedicled flaps, most commonly pectoralis major myocutaneous flap or other suitable pedicled options. Flap selection was based on tumour site, defect size and composition, patient fitness, vascular status, comorbidities, and availability of microsurgical resources.

 

Data collection

Demographic, clinicopathological, operative, and postoperative data were recorded. Baseline variables included age, sex, risk factors, comorbidities, tumour subsite, clinical stage, and histopathological diagnosis. Operative variables included type of resection, neck dissection, flap used, operative duration, blood loss, and hospital stay.

 

Outcome assessment

The primary outcomes were postoperative complications and functional recovery. Complications assessed included flap-related complications, wound infection, flap necrosis, orocutaneous fistula, donor-site morbidity, wound dehiscence, and need for re-exploration or secondary intervention. Functional outcomes included oral intake, speech, swallowing, and mouth opening. Quality of life was assessed during follow-up using the study’s predefined assessment parameters.

 

Secondary outcomes included delay in initiation of adjuvant therapy, recurrence, and mortality. Delay in adjuvant therapy was defined as initiation of postoperative radiotherapy or chemoradiotherapy beyond six weeks after surgery.

 

Follow-up

Patients were followed postoperatively for wound healing, flap viability, complications, functional recovery, adjuvant treatment status, recurrence, and survival. Follow-up data were obtained from outpatient visits, hospital records, and treatment documentation.

 

Statistical analysis

Data were entered and analysed using appropriate statistical software. Continuous variables were expressed as mean with standard deviation or median with range, depending on distribution. Categorical variables were expressed as frequencies and percentages. Comparisons between the free flap and pedicled flap groups were performed using the Chi-square test or Fisher’s exact test for categorical variables and the Student’s t test or Mann–Whitney U test for continuous variables, as appropriate. A p value of <0.05 was considered statistically significant.

 

RESULTS

Study cohort and baseline characteristics.

A total of 150 patients with oral cavity malignancy who underwent flap reconstruction after curative-intent resection were included. The free flap group comprised 70 (46.7%) patients, while the pedicled flap group comprised 80 (53.3%) patients. The cohort had 113 (75.3%) males and 37 (24.7%) females, with a mean age of 53.6 ± 10.9 years. Patients in the pedicled flap group were older than those in the free flap group (p < 0.001), and serum albumin was modestly lower in the pedicled flap group (p = 0.014). ASA status also differed between groups (p = 0.030). Other major habits and comorbidities were broadly comparable between the two groups.

 

Table 1. Baseline demographic and clinical characteristics by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Age, years

49.5 ± 10.6

57.1 ± 10.0

t = -4.54

<0.001

Sex: Male

52 (74.3)

61 (76.2)

χ² = 0.01

0.929

  Female

18 (25.7)

19 (23.8)

 

 

Residence: Rural

40 (57.1)

42 (52.5)

χ²(2) = 1.52

0.467

  Semi-urban

11 (15.7)

19 (23.8)

 

 

  Urban

19 (27.1)

19 (23.8)

 

 

BMI, kg/m²

21.4 ± 2.9

21.1 ± 3.1

t = 0.59

0.555

Hemoglobin, g/dL

12.0 ± 1.5

11.5 ± 1.4

t = 1.92

0.057

Serum albumin, g/dL

3.7 ± 0.4

3.6 ± 0.4

t = 2.48

0.014

ASA status: I

14 (20.0)

5 (6.2)

χ²(2) = 7.02

0.030

  II

41 (58.6)

50 (62.5)

 

 

  III

15 (21.4)

25 (31.2)

 

 

Hypertension

14 (20.0)

24 (30.0)

χ² = 1.48

0.224

Diabetes mellitus

12 (17.1)

22 (27.5)

χ² = 1.73

0.188

Ischemic heart disease

2 (2.9)

11 (13.8)

χ² = 4.30

0.038

Tobacco chewing

49 (70.0)

58 (72.5)

χ² = 0.02

0.875

Smoking

24 (34.3)

33 (41.2)

χ² = 0.50

0.479

Alcohol use

22 (31.4)

31 (38.8)

χ² = 0.58

0.444

Betel nut use

43 (61.4)

52 (65.0)

χ² = 0.08

0.777

Values are presented as mean ± SD or n (%). χ² = chi-square test; Fisher exact test used where appropriate.

 

Tumour and pathological characteristics.

Buccal mucosa was the most common primary site, accounting for 66 (44.0%) cases. Advanced-stage disease was frequent, with stage III or IV disease present in 111 (74.0%) patients. Tumour site, clinical T stage, nodal stage, AJCC stage, tumour size, depth of invasion, bone involvement, margin status, pathological nodal positivity, extranodal extension, and planned adjuvant therapy were not significantly different between reconstruction groups.

 

Table 2. Tumour and pathological characteristics by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Primary site: Buccal mucosa

28 (40.0)

38 (47.5)

χ² (5) = 7.38

0.194

  Oral tongue

15 (21.4)

14 (17.5)

 

 

  Lower alveolus/gingivobuccal sulcus

18 (25.7)

11 (13.8)

 

 

  Floor of mouth

6 (8.6)

10 (12.5)

 

 

  Retromolar trigone

2 (2.9)

7 (8.8)

 

 

  Lip

1 (1.4)

0 (0.0)

 

 

Clinical T stage: T1

6 (8.6)

6 (7.5)

χ²(3) = 1.03

0.794

  T2

21 (30.0)

30 (37.5)

 

 

  T3

18 (25.7)

17 (21.2)

 

 

  T4

25 (35.7)

27 (33.8)

 

 

Clinical N stage: N0

39 (55.7)

36 (45.0)

χ²(3) = 5.74

0.125

  N1

11 (15.7)

23 (28.7)

 

 

  N2

20 (28.6)

19 (23.8)

 

 

  N3

0 (0.0)

2 (2.5)

 

 

AJCC stage: I

4 (5.7)

4 (5.0)

χ²(3) = 0.09

0.993

  II

14 (20.0)

17 (21.2)

 

 

  III

29 (41.4)

32 (40.0)

 

 

  IV

23 (32.9)

27 (33.8)

 

 

Tumor size, cm

4.7 ± 1.7

4.6 ± 1.7

t = 0.10

0.921

Depth of invasion, mm

11.8 ± 5.4

10.8 ± 4.7

t = 1.28

0.204

Bone involvement

15 (21.4)

23 (28.7)

χ² = 0.71

0.401

Tumor grade: Well differentiated

11 (15.7)

17 (21.2)

χ²(2) = 1.49

0.475

  Moderately differentiated

45 (64.3)

52 (65.0)

 

 

  Poorly differentiated

14 (20.0)

11 (13.8)

 

 

Positive/close margin

4 (5.7)

9 (11.2)

χ² = 0.83

0.362

Pathological node positivity

33 (47.1)

46 (57.5)

χ² = 1.22

0.270

Extranodal extension

9 (12.9)

15 (18.8)

χ² = 0.58

0.448

Adjuvant therapy planned

57 (81.4)

67 (83.8)

χ² = 0.03

0.874

Values are presented as mean ± SD or n (%).

 

Operative and perioperative outcomes.

Radial forearm free flap was the most commonly used free flap (30 [42.9%]), followed by anterolateral thigh free flap (25 [35.7%]). In the pedicled flap group, pectoralis major myocutaneous flap was the predominant reconstruction (62 [77.5%]). Free flap reconstruction required significantly longer operative time and higher estimated direct cost. Pedicled flap reconstruction was associated with greater blood loss, longer hospital stay, and delayed initiation of oral intake, whereas ICU stay was longer in the free flap group. Transfusion requirement, tracheostomy use, and intraoperative complication frequency did not differ significantly between groups.

 

Table 3. Operative and perioperative outcomes by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Operative time, min

530.4 ± 77.4

386.1 ± 72.3

t = 11.75

<0.001

Estimated blood loss, mL

805.7 ± 230.4

919.5 ± 243.2

t = -2.94

0.004

Blood transfusion, units

0.8 ± 0.7

0.9 ± 0.8

t = -1.24

0.216

Tracheostomy performed

37 (52.9)

33 (41.2)

χ² = 1.58

0.209

Intraoperative complication

2 (2.9)

3 (3.8)

Fisher exact; OR = 1.32

1.000

ICU stay, days

2.4 ± 0.7

1.6 ± 0.8

t = 6.15

<0.001

Hospital stay, days

14.3 ± 3.6

17.8 ± 3.9

t = -5.76

<0.001

Day of oral intake

8.4 ± 1.9

10.6 ± 2.4

t = -6.43

<0.001

Estimated direct cost, INR

163583 ± 29019

97208 ± 16774

t = 16.83

<0.001

Values are presented as mean ± SD or n (%). Estimated direct cost is reported in Indian rupees.

 

Postoperative complications

The overall postoperative complication rate was higher in the pedicled flap group than in the free flap group. Overall complications occurred in 22 (31.4%) patients in the free flap group and 47 (58.8%) patients in the pedicled flap group (χ² = 10.15, p = 0.001). Donor-site morbidity was also higher in the pedicled flap group, affecting 16 (20.0%) patients compared with 4 (5.7%) patients in the free flap group (p = 0.020). Orocutaneous fistula occurred more frequently in the pedicled flap group, although this comparison did not reach conventional statistical significance.

 

Table 4. Postoperative complications and surgical morbidity by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Overall postoperative complication

22 (31.4)

47 (58.8)

χ² = 10.15

0.001

Flap compromise

3 (4.3)

2 (2.5)

Fisher exact; OR = 0.57

0.665

Partial/total flap loss

1 (1.4)

5 (6.2)

Fisher exact; OR = 4.60

0.216

Re-exploration

3 (4.3)

2 (2.5)

Fisher exact; OR = 0.57

0.665

Wound dehiscence

9 (12.9)

10 (12.5)

χ² = 0.00

1.000

Wound infection

7 (10.0)

15 (18.8)

χ² = 1.64

0.201

Orocutaneous fistula

1 (1.4)

7 (8.8)

Fisher exact; OR = 6.62

0.068

Donor-site morbidity

4 (5.7)

16 (20.0)

χ² = 5.42

0.020

Hematoma

0 (0.0)

3 (3.8)

Fisher exact

0.248

Chest complication

4 (5.7)

6 (7.5)

Fisher exact; OR = 1.34

0.751

Complication grade: None

48 (68.6)

33 (41.2)

χ²(2) = 11.30

0.004

  Minor

18 (25.7)

37 (46.2)

 

 

  Major

4 (5.7)

10 (12.5)

 

 

Values are presented as n (%). Fisher exact test was applied for sparse 2×2 comparisons.

Figure 1. Postoperative complications profile by reconstruction group

 

Functional outcomes

Functional recovery favoured the free flap group. Good speech intelligibility was recorded in 46 (65.7%) patients after free flap reconstruction compared with 21 (26.2%) patients after pedicled flap reconstruction (p < 0.001). Normal or near-normal oral diet was achieved in 46 (65.7%) patients in the free flap group and 34 (42.5%) patients in the pedicled flap group (p = 0.004). Mouth opening and quality-of-life scores were also significantly higher in the free flap group.

 

Table 5. Functional outcomes at follow-up by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Speech intelligibility: Good

46 (65.7)

21 (26.2)

χ²(2) = 26.09

<0.001

  Fair

24 (34.3)

52 (65.0)

 

 

  Poor

0 (0.0)

7 (8.8)

 

 

Swallowing outcome: Normal/near normal oral diet

46 (65.7)

34 (42.5)

χ²(2) = 11.18

0.004

  Soft/modified diet

24 (34.3)

40 (50.0)

 

 

  Feeding-tube dependent

0 (0.0)

6 (7.5)

 

 

Feeding tube at 1 month

4 (5.7)

17 (21.2)

χ² = 6.25

0.012

Feeding tube at 3 months

0 (0.0)

7 (8.8)

Fisher exact

0.015

Mouth opening, mm

29.5 ± 5.8

25.4 ± 5.5

t = 4.35

<0.001

QoL score (0–100)

68.0 ± 11.0

59.9 ± 12.7

t = 4.22

<0.001

Values are presented as mean ± SD or n (%). QoL = quality of life.

 

Figure2. Functional outcomes by reconstruction group

Adjuvant treatment and short-term oncological outcomes.

Adjuvant therapy was planned in a similar proportion of patients in both groups. Among patients for whom adjuvant therapy was planned, delay beyond 6 weeks was more frequent in the pedicled flap group. Adjuvant delay occurred in 29 (50.9%) planned cases in the free flap group and 55 (82.1%) planned cases in the pedicled flap group (χ² = 12.34, p < 0.001). During follow-up, recurrence and mortality did not differ significantly between the reconstruction groups.

 

Table 6. Adjuvant treatment and short-term oncological outcomes by reconstruction group

Variable

Free flap

Pedicled flap

Test statistic

p value

Follow-up duration, months

14.1 ± 5.7

15.1 ± 5.6

t = -1.04

0.302

Adjuvant therapy planned

57 (81.4)

67 (83.8)

χ² = 0.03

0.874

Adjuvant started among planned

56 (98.2)

64 (95.5)

Fisher exact; OR = 0.38

0.624

Adjuvant start day among treated

42.6 ± 9.9

51.3 ± 11.2

t = -4.55

<0.001

Adjuvant delay >6 weeks among planned

29 (50.9)

55 (82.1)

χ² = 12.34

<0.001

Recurrence

8 (11.4)

14 (17.5)

χ² = 0.67

0.414

Recurrence site: None

0 (0.0)

0 (0.0)

χ²(3) = 8.36

0.039

  Local

6 (8.6)

2 (2.5)

 

 

  Regional

0 (0.0)

0 (0.0)

 

 

Mortality

3 (4.3)

2 (2.5)

Fisher exact; OR = 0.57

0.665

Status at last follow-up: Alive disease-free

60 (85.7)

66 (82.5)

χ²(2) = 1.14

0.566

  Alive with disease

7 (10.0)

12 (15.0)

 

 

  Dead

3 (4.3)

2 (2.5)

 

 

Values are presented as mean ± SD or n (%). Percentages for adjuvant start and delay are calculated among patients with adjuvant therapy planned.

 

Adjusted analysis for overall postoperative complication.

 On multivariable logistic regression, pedicled flap reconstruction remained independently associated with higher odds of overall postoperative complication after adjustment for age, serum albumin, stage IV disease, and operative time. Longer operative time also showed a modest independent association with postoperative complications.

 

Table 7. Multivariable logistic regression for overall postoperative complication

Predictor

Adjusted OR (95% CI)

Wald z

p value

Pedicled flap reconstruction

7.17 (2.36-21.80)

3.47

<0.001

Age (per year)

0.99 (0.96-1.03)

-0.50

0.618

Serum albumin (per g/dL)

0.78 (0.34-1.76)

-0.61

0.545

Stage IV disease

1.14 (0.55-2.35)

0.35

0.726

Operative time (per 10 min)

1.05 (1.00-1.11)

2.14

0.032

 

Adjusted odds ratios are shown with 95% confidence intervals. The reference category for reconstruction type was free flap.

 

IMAGES

     
     

Oral cavity malignancies presenting in different sites of oral cavity

 

 

Karapandzic flap                                             Bilateral Nasolabial flap

 

Anterolateral Thigh( ALT) flap for reconstruction of oral cavity

 

 

 

 

   

Pectoralis  Major Myocutaneous (PMMC)  Flap

 

DISCUSSION

In this group, free flap reconstruction had fewer postoperative complications and better functional recovery than pedicled flap reconstruction. This is corroborated by Katsnelson et al., who reviewed 4,712 head and neck reconstruction cases from the ACS-NSQIP database and reported higher short-term postoperative morbidity with myocutaneous pedicled flaps, specifically infection, sepsis, and deep vein thrombosis, but no differences in readmission, reoperation, or length of stay. [9] Gabrysz-Forget et al., in a systematic review of 30 comparative studies, found that free flaps were associated with lower rates of infection and flap necrosis compared to pectoralis major myocutaneous flaps, but at the cost of longer operative time and higher cost. [10]

 

The improved speech, swallowing, mouth opening and quality of life in the free flap group is in line with previous functional studies. In a 13-year series of 114 patients reconstructed with either radial forearm free flap or pectoralis major myocutaneous flap, O'Neill et al. also reported significantly better speech performance with radial forearm free flap reconstruction. [12] Xiao et al. reported a 68.6% questionnaire response rate among 118 eligible patients and found better appearance, shoulder, and role-emotional domains after anterolateral thigh perforator free flap reconstruction compared with pectoralis major myocutaneous flap reconstruction. [13]

 

But free flaps aren't always the best option. Sittitrai et al. compared 171 oral cavity cancer patients (98 pedicled and 73 free flap reconstructions) and found no significant difference in the overall rate of complications at the recipient site, flap complications, speech, or swallowing. This is in keeping with the current interpretation that pedicled flaps are still suitable for selected patients, but free flaps are better for larger or more function demanding defects of the oral cavity.

The use of resources is a key factor in high volume centres. In resource-limited settings, where theatre time, microsurgical skills, monitoring facilities and cost are factors that affect reconstructive decision making, the findings of McCrory and Magnuson, and Forner et al., are relevant.

 

The increased delay to adjuvant therapy noted in the current study following pedicled flap reconstruction is clinically relevant. Postoperative radiotherapy or chemoradiotherapy may be postponed due to wound complications, flap necrosis, fistula, or dehiscence. Thus, the benefit of free flaps in the present study may be partly due to the decreased morbidity and earlier availability for adjuvant therapy.

 

Recurrence and mortality should be interpreted with caution as flap type alone is unlikely to affect tumour biology. Mahieu et al. evaluated 93 patients (64 pedicled and 29 free flap reconstructions), the majority of whom had oral cavity cancer. They did not find any significant differences in functional outcome, flap necrosis, complications, survival, recurrence or distant metastasis between the groups, and comorbidity was the most important factor affecting flap healing, not the type of flap used for reconstruction.

 

In conclusion, the current study confirms that free flap reconstruction is the method of choice in appropriate patients undergoing complex oral cavity reconstruction, especially when functional rehabilitation and timely adjuvant therapy are paramount. Pedicled flaps are still useful options in patients with extensive comorbidity, high anaesthetic risk, financial considerations, vessel depleted neck or limited microsurgical access. Flap selection should thus be tailored to the individual patient based on the nature of the defect, patient fitness, anticipated functional outcome, oncological treatment plan, and institutional resources.

 

CONCLUSION

Free flap reconstruction was correlated with better functional recovery, better quality of life, fewer postoperative complications and less delay in adjuvant therapy than pedicled flap reconstruction. These results suggest that microvascular free flaps are the best reconstructive choice for appropriate patients with complex oral cavity defects. However, pedicled flaps continue to have an important role in patients with significant comorbidity, high operative risk, financial limitations, or restricted access to microsurgical expertise. Hence, reconstruction should be tailored to the defect, patient, desired function and institutional resources.

 

REFERENCES

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–263. doi: 10.3322/caac.21834
  2. Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013;63(1):12–25. doi: 10.1111/j.1875-595X.2012.00131.x
  3. Ariyan S. The pectoralis major myocutaneous flap: a versatile flap for reconstruction in the head and neck. Plast Reconstr Surg. 1979;63(1):73–81. doi: 10.1097/00006534-197901000-00012
  4. Chana JS, Wei FC. A review of the advantages of the anterolateral thigh flap in head and neck reconstruction. Br J Plast Surg. 2004;57(7):603–609. doi: 10.1016/j.bjps.2004.05.032
  5. Ranganath K, Jalisi SM, Naples JG, Gomez ED. Comparing outcomes of radial forearm free flaps and anterolateral thigh free flaps in oral cavity reconstruction: a systematic review and meta-analysis. Oral Oncol. 2022;135:106214. doi: 10.1016/j.oraloncology.2022.106214
  6.  Jacobson MC, Franssen E, Fliss DM, Birt BD, Gilbert RW. Free forearm flap in oral reconstruction. Functional outcome. Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):959-64. doi: 10.1001/archotol.1995.01890090005001. PMID: 7646863.
  7.  Shah JP, Haribhakti V, Loree TR, Sutaria P. Complications of the pectoralis major myocutaneous flap in head and neck reconstruction. Am J Surg. 1990 Oct;160(4):352-5. doi: 10.1016/s0002-9610(05)80541-0. PMID: 2221234.
  8. Liu M, Liu W, Yang X, Guo H, Peng H. Pectoralis major myocutaneous flap for head and neck defects in the era of free flaps: harvesting technique and indications. Sci Rep. 2017;7:46256. doi: 10.1038/srep46256.
  1.  Katsnelson JY, Tyrell R, Karadsheh MJ, Manstein E, Egleston B, Deng M, Baltodano PA, Shafqat MS, Patel SA. Postoperative Complications Associated with the Choice of Reconstruction in Head and Neck Cancer: An Outcome Analysis of 4,712 Patients from the ACS-NSQIP Database. J Reconstr Microsurg. 2022 Jun;38(5):343-360. doi: 10.1055/s-0041-1733922. Epub 2021 Aug 17. PMID: 34404103; PMCID: PMC9073753.
  2. Gabrysz-Forget F, Tabet P, Rahal A, Bissada E, Christopoulos A, Ayad T. Free versus pedicled flaps for reconstruction of head and neck cancer defects: a systematic review. J Otolaryngol Head Neck Surg. 2019;48:13. doi:10.1186/s40463-019-0334-y.
  3.  Hsing CY, Wong YK, Wang CP, Wang CC, Jiang RS, Chen FJ, Liu SA. Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients--a quality of life analysis. Oral Oncol. 2011 Jun;47(6):522-7. doi: 10.1016/j.oraloncology.2011.03.024. Epub 2011 Apr 17. PMID: 21498107.
  4. O’Neill JP, Shine N, Eadie PA, Beausang E, Timon C. Free tissue transfer versus pedicled flap reconstruction of head and neck malignancy defects. Ir J Med Sci. 2010;179(3):337–343. doi:10.1007/s11845-010-0468-4.
  5. Xiao Y, Zhu J, Cai X, Wang J, Liu F, Wang H. Comparison between anterolateral thigh perforator free flaps and pectoralis major pedicled flap for reconstruction in oral cancer patients--a quality of life analysis. Med Oral Patol Oral Cir Bucal. 2013 Nov 1;18(6):e856-61. doi: 10.4317/medoral.19276. PMID: 24121914; PMCID: PMC3854077.
  6. Sittitrai P, Ruenmarkkaew D, Klibngern H. Pedicled flaps versus free flaps for oral cavity cancer reconstruction: a comparison of complications, hospital costs, and functional outcomes. Int Arch Otorhinolaryngol. 2023;27(1):e32–e42. doi:10.1055/s-0042-1751001.
  7. McCrory AL, Magnuson JS. Free tissue transfer versus pedicled flap in head and neck reconstruction. Laryngoscope. 2002;112(12):2161–2165. doi:10.1097/00005537-200212000-00006.
  8.  Forner D, Phillips T, Rigby M, Hart R, Taylor M, Trites J. Submental island flap reconstruction reduces cost in oral cancer reconstruction compared to radial forearm free flap reconstruction: a case series and cost analysis. J Otolaryngol Head Neck Surg. 2016 Feb 5;45:11. doi: 10.1186/s40463-016-0124-8. PMID: 26846792; PMCID: PMC4743171.
  9.  Chen MM, Harris JP, Orosco RK, Sirjani D, Hara W, Divi V. Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 Jun;158(6):1051-1056. doi: 10.1177/0194599817751679. Epub 2018 Jan 9. PMID: 29313448.
  10. Mahieu R, Colletti G, Bonomo P, et al. Head and neck reconstruction with pedicled flaps in the free flap era. Acta Otorhinolaryngol Ital. 2016;36(6):459–468. doi:10.14639/0392-100X-1153. 
Recommended Articles
Research Article Open Access
Neonatal Sepsis in a Tertiary Care NICU: A Prospective Observational Study of Clinical Profile, Risk Factors, Microbial Spectrum, and Short-Term Outcomes
2026, Volume-7, Issue 3 : 933-942
Research Article Open Access
An Observational Study of Incidence and Risk Factors of Incisional Hernia After Abdominal Surgery at a Tertiary Care Hospital
2026, Volume-7, Issue 3 : 955-965
Research Article Open Access
Incidence and Risk Factors for Postoperative Delirium in Elderly for Abdominal Surgeries Under General Anaesthesia
2026, Volume-7, Issue 3 : 943-951
Case Report Open Access
An Uncommon Case of Multiple Cutaneous Leiomyomas Without Systemic Association
2026, Volume-7, Issue 3 : 952-954
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
3 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved